Resetting the agenda: a new approach to mild asthma Source: International Congress 2019 – New recommendations and priorities for asthma management Year: 2019
NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020
Treatable traits: a step closer to the “holy grail” of asthma control? Source: Eur Respir J, 55 (3) 2000002; 10.1183/13993003.00002-2020 Year: 2020
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Exploring new frontiers: the role of simulation as an educational strategy Source: Breathe 2013; 9: 497-501 Year: 2013
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021
Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013
Scene-setting: why do we need genomics and proteomics to understand pathology? Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
Developing integrated handprints of severe asthma: the U-BIOPRED approach Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
The genetics of asthma and the promise of genomics-guided drug discovery Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020
COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007
Improving our patients' understanding of their asthma Source: International Congress 2019 – Medical education Year: 2019
Crowdfunding for respiratory research: a new frontier for patient and public engagement? Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017 Year: 2017
Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019